Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

Rhea-AI Summary

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) is set to release its first quarter 2023 financial results after market close on May 4, 2023. The announcement includes a live conference call and webcast scheduled for 4:30 p.m. ET, with dial-in numbers provided for U.S. and international participants.

The company focuses on developing specialty pharmaceuticals aimed at serious medical conditions. Collegium's commitment to improving patient lives underlines its strategic positioning within the pharmaceutical sector. The earnings call will offer insights into Collegium's financial performance and future outlook, attracting attention from investors keen on the company's financial metrics.

STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2023 financial results after the market closes on Thursday, May 4, 2023. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.

Conference Call Information 
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2023 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact:
Christopher James, M.D.                                                                                       
Vice President, Investor Relations
ir@collegiumpharma.com

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com

FAQ

When will Collegium Pharmaceutical report its Q1 2023 financial results?

Collegium Pharmaceutical will report its Q1 2023 financial results after market close on May 4, 2023.

What time is the Q1 2023 earnings call for Collegium Pharmaceutical?

The earnings call will take place at 4:30 p.m. ET on May 4, 2023.

How can I access the Collegium Pharmaceutical earnings call?

The earnings call can be accessed by dialing (877) 407-8037 for U.S. participants and (201) 689-8037 for international callers.

Where can I find the webcast for the Q1 2023 earnings call?

The webcast will be available on Collegium Pharmaceutical's Investors section of their website.